Highlights

  • BluGlass reported FY26 customer Revenue of A$4.06 million and a net loss after tax of A$10.39 million.
  • Customer receipts reached A$1.66 million in the September 2026 quarter, with cash of A$8.66 million at quarter end.
  • An FY26 R&D Tax Incentive refund of A$6.1 million arrived in October, partly repaying the new Rockford loan.
  • Shareholders carried all eleven resolutions at the 23 October 2026 AGM, including director elections and Placement capacity.

A new A$8.0 million Research and Development financing Facility has reshaped the funding position of BluGlass (ASX:BLG), the Australian developer of gallium nitride (GaN) visible lasers. The facility with Rockford, announced on 23 September 2026, replaced a A$2.27 million Radium facility and freed up more than A$5 million in additional liquidity.

Two days earlier, the company announced an early-stage collaboration with global photonics group Coherent to assess a novel GaN-based device for scientific and medical applications, adding to a run of customer-funded development programmes.

Non-Dilutive Funding Backed by Tax Refunds

The Rockford facility carries interest of 16.5% a year and is secured first against the FY26 and FY27 R&D Tax Incentive refunds. It was fully drawn on 25 September 2026. The FY26 refund of A$6.1 million, received in October, allowed BluGlass to apply A$2.75 million to the scheduled repayment, with the balance due from the FY27 refund and no later than 1 March 2028.

In the September 2026 quarter, customer receipts were A$1.66 million and net operating cash outflow was A$3.12 million, leaving cash of A$8.66 million at 30 September.

FY26 Revenue Dips as Development Contracts Accumulate

For FY26, the year to 30 June 2026, revenue from customers fell to A$4.06 million from A$5.45 million as project and foundry revenue declined, although laser diode product sales rose to A$498,212. Total income, including R&D Tax Incentive income of A$6.12 million, was A$10.48 million, and the net loss narrowed 5% to A$10.39 million. Equity raisings, led by a placement at A$0.24 a share, brought in net proceeds of about A$14.6 million.

The company signed five new development contracts worth just under A$5.2 million during the year, including a A$1.05 million Year 3 extension with the US Department of War, a A$1.25 million programme with a tier-one defence prime and a A$1.3 million collaboration with a Fortune 500 data storage company. In July 2026 it added a A$1.4 million Phase II contract from US photonics firm Uviquity, in which it also invested US$1.5 million through a promissory note. BluGlass also set a world record for single-mode GaN laser peak power at 1.9W.

FY27 Priorities Centre on Pipeline Conversion

Management aims to convert a US$100 million project pipeline into paid development contracts and repeat orders, target programmes in defence, aerospace, quantum, biotech and consumer electronics, and deepen US Government relationships to access non-dilutive funding. It also plans Investment in fabrication equipment and staff, and continues to pursue organic and inorganic growth. The Coherent feasibility work is expected to run three to five months. No quantitative guidance has been issued, and the Annual Report flagged a material uncertainty regarding going concern.

Jim Haden, appointed managing director in July, and new non-executive director Yam Rubenstein were both elected at the AGM. Shares were unchanged at A$0.185 on 2 November 2026, with a Market Capitalisation of A$35.62 million and a 28.85% decline over 12 months.